Investment

down-icon
image
US Stocks
image
Invest in the world’s largest market with US Stocks
image
Crypto
image
Unleash the unlimited potential of Crypto
image
Mutual Funds
image
Worry-free investments with Mutual Funds
image
Gold
image
The simplest way to invest in Gold
image
Options
image
Maximize market opportunities with Options Trading
image
Explore
image
Choose from 1000+ available assets

Features

down-icon
support-icon
Pro Tools for Pro Traders
Uncover the powerful trading features

Pro Features

icon

Pluang Web Trading

icon

Leverage

icon
support-icon
Built for Investors
Experience investing with simplified features

Pockets

icon

Recurring Buy

icon

USD Yield

icon

Pluang Cuan

icon

Fees

Safety

Academy

down-icon
image
Latest for You
image
Get up-to-date financial news and investing tips & information
image
Blog
image
Find various tips & information to become a knowledgeable investor
image
News and Analysis
image
Read the latest information about finance and investment
image
Learn
image
Become a smarter investor by learning the basics of investing
image
Glossary
image
Learn investment terms to understand investing better

More

down-icon
image
Promo & Referral
image
Discover exclusive opportunities to level up your investments
image
Investment Clubs (Coming Soon)
image
Join hands with like-minded investors to grow wealth together
image
Press (Coming Soon)
image
Stay updated with our latest news and media coverage
support-icon
Support

About Us

arrow-icon

Contact

arrow-icon

Ask

arrow-icon

Career

arrow-icon

Tax Reporting Guide

arrow-icon

Pluang+

|

assetIcon

BridgeBio Pharma Inc (BBIO) Stock Price Today

Overview

Financial

Technicals

Analysis

Corporate Action

About

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Technical Indicators

|

|

|

Overall Summary

Bearish (4)

Neutral (5)

Bullish (18)

Performance

BBIO ROI

arrow
-17.27%

% from 52W High

-46.64%
$23.42

52W Low: $22.35

18 Nov 2024

52W High: $43.89

27 Dec 2023

News

Pluang News
Pluang News

Globe Newswire

5mo

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Pluang News
Pluang News

Globe Newswire

6mo

BridgeBio Pharma to Participate in the 45th Annual Goldman Sachs Global Healthcare Conference

Pluang News
Pluang News

Globe Newswire

6mo

BridgeBio Announces Durable Month 12 and 18 Phase 2 Cohort 5 Results of Oral Infigratinib in Achondroplasia, and First Participant Consented in ACCEL for Hypochondroplasia

Pluang News
Pluang News

Globe Newswire

6mo

BridgeBio to Host Call on Month 12 and 18 Phase 2 Cohort 5 Results of Oral Infigratinib in Achondroplasia on June 4, 2024

Pluang News
Pluang News

Globe Newswire

6mo

Additional Data Showing Acoramidis Increases Serum Transthyretin Which is Associated with Improved Cardiovascular Outcomes Presented at ISA from BridgeBio Pharma’s Phase 3 ATTRibute-CM Study in Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

People Also Bought

Pluang
Pluang
DIS
Walt Disney Co
+0.81%

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Let’s trade or invest in this asset by signing up or logging in!

register_card

Let’s trade or invest in this asset by signing up or logging in!

You can also download our app!

item
item
item